Dermatologic Manifestations of Generalized Lipodystrophy Clinical Presentation

  • Author: Camila K Janniger, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: May 27, 2011
 

Physical

Two forms of generalized lipodystrophy exist, congenital and acquired, which have different clinical features.

Congenital generalized lipodystrophy

The diagnosis of generalized lipodystrophy often is obvious from birth because of the extraordinary lack of subcutaneous fat. Fat cells are present but are reduced in number and size and contain little fat. Anabolic features are observed at birth, with enlarged visceral organs. Toddlers may have a potentially dangerous hyperplasia of pharyngeal tonsils and adenoids. Lipodystrophy produces a distinctive facies.

A well-defined musculature with prominent superficial veins is one of the earliest manifestations.

Clitoral or penile hypertrophy has been evident at birth, but genitomegaly is not apparent after puberty.

The earliest skin manifestations include AN, eruptive xanthomas, hirsutism, and thick, tightly curled scalp hair that extends nearly to the eyebrows. Hirsutism of the face, neck arms, and legs may be observed at birth in some patients and tends to increase. No special growth of the pubic or axillary hair occurs.

All patients with Lawrence-Seip syndrome and lipodystrophy have AN to some degree. AN can diminish and disappear with puberty and is said to be prominent on the elbows, knees, and waist, as well as the more typical sites of the neck and axillae.

Acromegalic gigantism with advanced bone age and advanced dentition is an early and constant feature. The growth rate is most marked in the first 4 years, and these children may attain more than 90% of their adult growth within the first 10 years of life. Growth subsequently slows, and normal or short stature as adults usually is observed. Lipoatrophy does not affect female breast development at puberty, although females with this congenital lipodystrophy syndrome have a masculine habitus with marked muscularity.

Liver disease with fatty metamorphosis and cirrhosis is another constant feature, and hepatosplenomegaly tends to produce a markedly protuberant abdomen.

Childhood death due to massive GI bleeding has been reported frequently.

Diabetes mellitus usually begins in the teenage years. The diabetes is insulin resistant, and despite poor control of the diabetes, ketosis tends to be absent. Hyperlipemia usually precedes the diabetes.

An increased basal metabolic rate is a frequent finding.

Dilatation of the cerebral ventricular system has been described in most patients with generalized lipodystrophy. Intelligence may range from normal to subnormal.

Kidneys may be enlarged without apparent histologic cause, and renal failure may ensue.

Cardiomegaly frequently is observed with muscle hypertrophy and ventricular disfunction. Increased chamber size may be demonstrated on echocardiogram with a systolic ejection murmur. Peripheral artery stenosis may be associated with reduced exercise tolerance, cardiac murmurs, and, possibly, pulmonary hypertension. Occasionally, congenital anomalies of the heart, bones, and kidneys also are found. These patients have abnormal autonomic modulation, reflected by an increased heart rate and a pronounced reduction in heart rate variability.[2]

The presence of dental abnormalities such as talon cusps, macrodontia, and aberrant tooth morphology has been described.[3]

Acquired generalized lipodystrophy

Generalized lipodystrophy often is preceded by an illness and, in many instances, an infection. The fat loss becomes apparent either focally or diffusely, usually beginning in adolescence or early adult life.

Most of the features of the congenital form may occur, but in the acquired form, neurologic, cardiac, and renal abnormalities usually are absent. Bone age is normal and genital hypertrophy is absent. AN to varying degrees probably is a constant finding in acquired and congenital forms.

Autoimmune disorders also may be common, including Coombs-positive hemolytic anemia and chronic nephritis; however, great variability exists in the immunologic abnormalities in patients with the acquired form. Patients with the acquired form of generalized lipodystrophy also are prone to infection.

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Camila K Janniger, MD  Clinical Professor of Dermatology, Clinical Associate Professor of Pediatrics, Chief of Pediatric Dermatology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Camila K Janniger, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Coauthor(s)

Cris Jagar, MD  Staff Physician, Department of Psychiatry, Trinitas Regional Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Albert C Yan, MD  Section Chief, Associate Professor, Department of Pediatrics, Section of Dermatology, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine

Albert C Yan, MD is a member of the following medical societies: American Academy of Dermatology, American Academy of Pediatrics, Society for Investigative Dermatology, and Society for Pediatric Dermatology

Disclosure: Nothing to disclose.

Michael J Wells, MD  Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Glen H Crawford, MD  Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital

Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Department of Dermatology, Geisinger Medical Center

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References
  1. Jin J, Cao L, Zhao Z, et al. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus. Eur J Endocrinol. Dec 2007;157(6):783-7. [Medline].

  2. Faria CA, Moraes RS, Sobral-Filho DC, Rego AG, Baracho MF, Egito ES, et al. Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome). Europace. Apr 17 2009;[Medline].

  3. Solanki M, Patil SS, Baweja DK, Noorani H, Pk S. Talon cusps, macrodontia, and aberrant tooth morphology in Berardinelli-Seip syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Jan 2008;105(1):e41-7. [Medline].

  4. Rego AG, Mesquita ET, Faria CA, et al. [Cardiometabolic abnormalities in patients with berardinelli-Seip syndrome]. Arq Bras Cardiol. Jan 2010;94(1):109-18. [Medline].

  5. Al-Attar SA, Pollex RL, Robinson JF, Miskie BA, Walcarius R, Little CH, et al. Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging. BMC Med Imaging. 2007;7:3. [Medline].

  6. Mork NJ, Rajka G, Halse J. Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy). Acta Derm Venereol. 1986;66(2):173-4. [Medline].

  7. Miehle K, Stumvoll M, Fasshauer M. [Lipodystrophy : Mechanisms, clinical presentation, therapy.]. Internist (Berl). Apr 2011;52(4):362-373. [Medline].

  8. Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism. Apr 2004;53(4):513-9. [Medline].

  9. Gorden P, Gavrilova O. The clinical uses of leptin. Curr Opin Pharmacol. Dec 2003;3(6):655-9. [Medline].

  10. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. Jul 2005;54(7):1994-2002. [Medline].

  11. Oral EA, Chan JL. Rationale for leptin-replacement therapy for severe lipodystrophy. Endocr Pract. Mar-Apr 2010;16(2):324-33. [Medline].

  12. Asano S, Matsuki S, Ozawa Y, Saruta T, Nagashima M. A case of Seip-Lawrence syndrome with acanthosis nigricans. Keio J Med. Sep 1966;15(3):101-10. [Medline].

  13. Dhar V, Deorari AK, Kalra V. Seip-Lawrence syndrome (congenital generalised lipodystrophy)--a case report. Indian J Pediatr. Nov-Dec 1982;49(401):881-4. [Medline].

  14. Francis GA, Li G, Casey R, Wang J, Cao H, Leff T, et al. Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3). BMC Med Genet. 2006;7:3. [Medline].

  15. Fu M, Kazlauskaite R, Baracho Mde F, Santos MG, Brandao-Neto J, Villares S, et al. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. J Clin Endocrinol Metab. Jun 2004;89(6):2916-22. [Medline].

  16. Hegele RA, Joy TR, Al-Attar S, Rutt BK. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res. Mar 20 2007;[Medline].

  17. Janaki VR, Premalatha S, Rao NR, Thambiah AS. Lawrence-Seip syndrome. Br J Dermatol. Dec 1980;103(6):693-6. [Medline].

  18. Mahmoud SF. Lawrence-Seip syndrome: report of a case from Egypt. Cutis. Aug 1997;60(2):91-3. [Medline].

  19. Peinado Cabrera EJ, Bernat Condomina G, Serrano Corredor S, Navarro Tellez MP, Moragon Gordon M. [Seip-Lawrence syndrome associated with polyostotic fibrous dysplasia. Report of a case]. An Med Interna. Mar 1997;14(3):135-8. [Medline].

  20. Prasad AN. Berardinelli seip syndrome. Indian Pediatr. Dec 2005;42(12):1245. [Medline].

  21. Raygada M, Rennert O. Congenital generalized lipodystrophy: profile of the disease and gender differences in two siblings. Clin Genet. Jan 2005;67(1):98-101. [Medline].

  22. Reed WB, Dexter R, Corley C, Fish C. Congenital lipodystrophic diabetes with acanthosis nigricans. The Seip-Lawrence syndrome. Arch Dermatol. Apr 1965;91(4):326-34. [Medline].

  23. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. Jul 1994;31(1):1-19; quiz 20-2. [Medline].

  24. Wacharasindhu S, Veerakul K, Likitmaskul S, Punnakanta L, Angsusingha K, Tuchinda C, et al. Congenital generalized lipodystrophy, a case report. Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:44-6. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.